Please review the following CME information before selecting the Begin the Program button found at the bottom of this page.
PROGRAM DESCRIPTION
Though experiencing dynamic growth, cosmetic dermatology is still a relatively new area of investigation in dermatology. As it evolves, innovative treatments and cosmetic procedures are emerging with the use of medical devices and/or drugs, in combination and beyond approved indications, to prevent or reverse patterns of aging or the deleterious effects on skin of systemic diseases such as HIV and AIDS. Botulinum toxin therapy and new skin fillers such as hyaluronic acid or poly-l-lactic acid are injected or implanted under the skin using particular techniques. The techniques require physician and health practitioners training as well as a thorough understanding of the advantages and drawbacks of each of the different implantation materials.
Recent advances have yielded a multitude of treatment options. Until now, however, little training has been available to maximize these options. This live satellite symposium and injection techniques workshop will present a comprehensive review of the new dermal fillers and their appropriate usage. It will cover facial aging, facial treatment zones, regional facial contouring, an overview of filling agents and the role of dermal augmentation. Particular injection techniques will be demonstrated.
Intended Audience
This activity has been developed for dermatologists, plastic surgeons, fellows and residents in plastic surgery and dermatology.
EDUCATIONAL OBJECTIVES
Upon completion of this activity, participants should be able to:
- Assess patient face and needs and understand the role fillers play in the treatment of aging skin;
- Describe and discuss the differences between stimulatory and replacement fillers;
- Make decisions on which treatment options are appropriate for correcting facial volume depletion including recently approved and investigational fillers; and
- Physician should also be able to communicate the risk associated with implantation
Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Elsevier Office of Continuing Medical Education (EOCME) and Skin & Allergy News. The EOCME is accredited by the ACCME to provide continuing medical education (CME) for physicians.
CME Credit Statement
The EOCME designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credit(s). Physicians should only claim credit commensurate with the extent of their participation in the activity.
FACULTY DISCLOSURES
As a sponsor accredited by the ACCME, it is the policy of the EOCME to require the disclosure of anyone who is in a position to control the content of an educational activity. All relevant financial relationships with any commercial interests and/or manufacturers must be disclosed to participants at the beginning of each activity. The faculty of this educational activity discloses the following.
Dr Vleggaar is a consultant to Dermik Aesthetics. He will discuss the use of poly-l-lactic acid for cosmetic use. Dr Werschler is a consultant, advisory board member, investigator, speaker for Allergan, Bioform, Dermik, Myoscience, DermAvance, 3M, Galderma, Johnson & Johnson, Pfizer, Revance, Steifel, Astellis, Inamed. He will discuss the use of poly-l-lactic acid for cosmetic use.
resolution of conflict of Interest
The EOCME has implemented a process to resolve conflict of interest for each CME activity. In order to help ensure content objectivity, independence, and fair balance, and to ensure that the content is aligned with the interest of the public, the EOCME has resolved the conflict by external content review.
Unapproved/Off-Label Use Disclosure
The EOCME requires CME faculty to disclose to the participants:
- When products or procedures being discussed are off-label, unlabeled, experimental, and or investigational (not US Food and Drug Administration [FDA] approved); and
- Any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research; interim analyses; and/or unsupported opinion.
Faculty may discuss information about pharmaceutical agents that are outside of FDA-approved labeling. This information is intended solely for CME and is not intended to promote off-label use of these medications. If you have questions, contact the medical affairs department of the manufacturer for the most recent prescribing information.
FINANCIAL SUPPORT
This CME activity is supported by an educational grant from 
a business of sanofi-aventis U.S.
Special Needs
We encourage participation by all individuals. If you have any special needs, please contact mededinfo@elsevier.com for assistance.
Hardware and Software Specifications Needed to View
This course requires use of a modern web browser such as Microsoft Internet Explorer, Mozilla Firefox, Apple Safari, Netscape, or Opera. Additionally, to view the presentations requires Flash reader version 6 or later (free download here) and Acrobat Reader Version 5 or later (free download here).